Oxana Denisova profile picture

Oxana
Denisova

Postdoctoral Researcher, Turku Bioscience Centre
PhD
INFLAMES Flagship

Contact

Tykistökatu 6
20520
Turku

Areas of expertise

Cancer cell signaling
kinases
protein phosphatases
anticancer and antiviral agents, virus-host interaction

Biography

Education and degrees completed

2014 PhD in Medicine, Faculty of Medicine, University of Helsinki, Finland. 

2007 MSc in Biology (Molecular Biology) (Hons.), Lobachevsky State University of Nizhny Novgorod, Russia.


Current position

09/2022 – to date       Senior Postdoc, Turku Bioscience Centre, University of Turku & Åbo Akademi University, Turku, Finland

Previous work experience

01/2015 – 07/2022    Postdoctoral Researcher, Novel targeted therapy for human malignant glioblastoma with Professor Jukka Westermarck, Turku Bioscience Centre, University of Turku & Åbo Akademi University, Turku, Finland

06/2011 – 05/2014    PhD Researcher, Influenza virus-host interactions and their modulation by small molecules with Docent Denis Kainov, Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland

10/2008 – 06/2011    Junior Researcher, Institute of Theoretical and Experimental Biophysics, Pushchino, Russia

09/2007 – 10/2008    Junior Researcher, Institute of Protein Research, Pushchino, Russia

09/2005 – 05/2007    Visiting Master student, Development of genomic approach for high-throughput analysis of CCWGG methylation with Professor Nicholas I. Matvienko, Molecular Biology Education Centre, Institute of Protein Research, Pushchino, Russia

Career breaks

05/2020 – 08/2021     Maternity leave

05/2016 – 08/2017     Maternity leave

Research

I am a PhD-trained scientist with over 15 years of research experience in molecular biology, cell signaling, and anticancer therapy development. My current research focuses on brain cancer vulnerabilities, with a particular focus on glioblastoma and pediatric medulloblastoma. I have extensive expertise in preclinical in vivo models.

Publications

Sort by:

PP2A-based triple-strike therapy overcomes mitochondrial apoptosis resistance in brain cancer cells (2023)

Molecular Oncology
Denisova Oxana V., Merisaari Joni, Huhtaniemi Riikka, Qiao Xi, Yetukuri Laxman, Jumppanen Mikael, Kaur Amanpreet, Pääkkönen Mirva, von Schantz-Fant Carina, Ohlmeyer Michael, Wennerberg Krister, Kauko Otto, Koch Raphael, Aittokallio Tero, Taipale Mikko, Westermarck Jukka
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Thioridazine inhibits autophagy and sensitizes glioblastoma cells to temozolomide (2019)

International Journal of Cancer
Tor‐Christian Johannessen, Md Mahdi Hasan‐Olive, Huaiyang Zhu, Oxana Denisova, Amra Grudic, Md Abdul Latif, Halala Saed, Jobin K. Varughese, Gro Vatne Røsland, Ning Yang, Terje Sundstrøm, Anne Nordal, Karl Johan Tronstad, Jian Wang, Morten Lund‐Johansen, Anne Simonsen, Bassam Janji, Jukka Westermarck, Rolf Bjerkvig, Lars Prestegarden
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

PP2A inhibitor PME-1 drives kinase inhibitor resistance in glioma cells (2016)

Cancer Research
Amanpreet Kaur, Oxana V. Denisova, Xi Qiao, Mikael Jumppanen, Emilia Peuhu, Shafiq U. Ahmed, Olayinka Raheem, Hannu Haapasalo, John Eriksson, Anthony J. Chalmers, Pirjo Laakkonen, Jukka Westermarck
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))